Sanofi
SNYFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
48,272
Cost of Revenue
14,393
Gross Profit
33,878
Gross Margin
70.2%
Operating Income
7,905
Operating Margin
16.4%
Net Income
6,060
Net Margin
12.6%
EPS (Basic)
$2.19
EPS (Diluted)
$2.19
EBITDA
12,026
EBITDA Margin
24.9%
2023
12/31/2023
Revenue
45,364
Cost of Revenue
13,765
Gross Profit
31,599
Gross Margin
69.7%
Operating Income
7,586
Operating Margin
16.7%
Net Income
5,886
Net Margin
13.0%
EPS (Basic)
$2.15
EPS (Diluted)
$2.15
EBITDA
12,415
EBITDA Margin
27.4%
2022
12/31/2022
Revenue
44,211
Cost of Revenue
12,951
Gross Profit
31,260
Gross Margin
70.7%
Operating Income
11,077
Operating Margin
25.1%
Net Income
9,124
Net Margin
20.6%
EPS (Basic)
$3.19
EPS (Diluted)
$3.18
EBITDA
14,726
EBITDA Margin
33.3%
2021
12/31/2021
Revenue
42,701
Cost of Revenue
13,358
Gross Profit
29,343
Gross Margin
68.7%
Operating Income
8,857
Operating Margin
20.7%
Net Income
6,783
Net Margin
15.9%
EPS (Basic)
$2.49
EPS (Diluted)
$2.49
EBITDA
12,576
EBITDA Margin
29.5%
2020
12/31/2020
Revenue
40,732
Cost of Revenue
13,253
Gross Profit
27,479
Gross Margin
67.5%
Operating Income
15,383
Operating Margin
37.8%
Net Income
13,400
Net Margin
32.9%
EPS (Basic)
$4.91
EPS (Diluted)
$4.91
EBITDA
19,492
EBITDA Margin
47.9%